Gynecological cancers: a turquoise-themed start to the school year to raise awareness

Disclosure: This website contains affiliate links, which means we will receive a commission if you purchase through the same.

Since 2017, the Turquoise September campaign has been raising awareness about tumors affecting the uterus, fallopian tubes, ovaries, vagina, and vulva. Associations, healthcare professionals, and hospitals are increasing their efforts to raise awareness and support affected women.

Each year in France, more than 18,000 women are diagnosed with gynecological cancer, and approximately 7,000 die from it. Behind these figures lie several diseases affecting the cervix, endometrium, ovaries, vulva, fallopian tubes, or vagina. While endometrial cancer is the most common, ovarian cancer remains particularly deadly, notably because its symptoms, often subtle and nonspecific, sometimes delay diagnosis.

Raising awareness is precisely the goal of Turquoise September. Throughout the month, this national campaign reminds people of the ways to prevent cervical cancer through vaccination against human papillomavirus (HPV) and organized screening for women between the ages of 25 and 65. For other gynecological cancers, which are not systematically screened for, the campaign urges people not to dismiss unusual bleeding, persistent pelvic pain, abdominal bloating, or unexplained urinary and digestive problems.

Advertisements

Words against pain

Led in particular by the IMAGYN association, the 2026 mobilization includes 88 events across France. Information booths in healthcare facilities, conferences, meetings with healthcare professionals, workshops, webinars, and fundraising events will help women, patients, and their loved ones better understand these diseases and their treatments. COCON and its village, a mobile unit created by the association, will also reach out to the public to offer a space for listening and discussion on topics that are still too often taboo, such as sexuality, fertility, and theafter-effects of treatments.